Off-Label Treatments

Off-Label Treatments COVID Off-Label is an education project of MedInsight. COVID Off-Label is a public education project of The MedInsight® Institute.

We are a 501(c)(3) non-profit organization with a mission of saving lives and easing suffering through educating about new treatment options using well-established, unpromoted, low-cost generic drugs. Through COVID Off-Label, we aim to educate the public and physicians about safe, low-cost, accessible treatment choices for COVID-19 and Long-COVID. Under the leadership of Moshe Rogosnitzky, a scien

tist and MedInsight's co-founder, and the advising of a board of researchers, physicians, and subject experts, COVID Off-Label, brings together research and information on repurposed drugs that have been showing a positive impact on COVID-19 and Long-COVID patients in clinical trials. As a non-profit organization, we rely solely on the generosity of our donors to create and maintain the information provided on the COVID Off-Label website. Please support our efforts by making a tax-deductible donation or join our efforts in other ways.

10/23/2022

Fluvoxamine and the Early of COVID: What does the data say?👇

👩‍⚕Dr. Risinger explains the rationale behind the use of (Luvox) for treating early COVID-19.

10/23/2022

Study going on about the role of lipid metabolism, and is there a strategy for some -lowering in the treatment of . Dr. John Whyte, chief medical officer at WebMD discusses fenofibrate as a potential for COVID-19.

10/23/2022

For COVID patients who have not been vaccinated, the antidepressant could help save lives. Joel Grover reported on NBC4 News on Monday, March 22, 2021.

is a well-established heartburn drug, first approved in 1981 for treating peptic ulcers or gastroesophageal reflux dis...
10/02/2022

is a well-established heartburn drug, first approved in 1981 for treating peptic ulcers or gastroesophageal reflux disease (GERD). It is sold over the counter (OTC) without a prescription under various brand names, the most well-known of which is Pepcid.

Read the key facts for famotidine for COVID-19 and see the clinical trial results here👉https://covidofflabel.org/drug/famotidine/

10/02/2022

Studied As COVID-19 Treatment

Researchers in New York City is exploring whether famotidine, the active ingredient in Pepcid, could be used to treat COVID-19.

Welcome to easy-to-read summaries of the latest research into SAFE (Secure, Affordable, Feasible, and Effective) generic...
10/02/2022

Welcome to easy-to-read summaries of the latest research into SAFE (Secure, Affordable, Feasible, and Effective) generic off-patent drugs that have been showing promise for treating covid-19 and long-covid in clinical trials.

Learn More: https://bit.ly/3EcUD9m

Address

New City, NY
10128

Website

Alerts

Be the first to know and let us send you an email when Off-Label Treatments posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Organization

Send a message to Off-Label Treatments:

Shortcuts

Share

Category